While we are a clinical department within the U-M Medical School, the Department of Internal Medicine is also home to more than 130 basic, translational, and clinical research faculty members. Spread across 13 divisions, our research community successfully competes for funding from national agencies, foundations, and industry sponsored projects. Our scientists are dedicated to identifying and implementing real solutions to redefine how we practice medicine. We understand that great science can dramatically transform the lives of our patients here in Michigan and beyond.
BY THE NUMBERS
U-M, which has ranked No. 1 in research volume among the nation’s public universities for the past nine years, reported $1.62 billion in research expenditures during 2019. Among U-M units the Medical School ranked No. 1 in research expenditures, with $690 million. More than a third of that funding comes from the work of internal medicine faculty. In 2019, the Department of Internal Medicine competed for and obtained $198 million in research support and published more than 2,200 research publications.
COVID-19 RELATED RESEARCH
Department of Internal Medicine researchers across our specialties are conducting COVID-19 research to learn more about the disease and to develop improved and more personalized treatment methods. The below articles highlight some of their work.
Subset of COVID-19 Patients Have Increased Bleeding Risk
A multidisciplinary team of Michigan Medicine researchers identify a potential clinical biomarker for high bleeding risk and poorer outcomes in COVID-19. Read more.
County by County, Study Shows Social Inequality in COVID-19’s Toll
Renuka (Renu) Tipirneni, MD, MSc finds that the higher a county’s score on a national index of social vulnerability, the more cases and deaths per 100,000 – highlighting the role of social factors in spread. Read more.
COVID-19 Deaths Really Are Different. But Best Practices for ICU Care Should Still Apply
Michigan Medicine researchers examine the specific cause of death in critically ill coronavirus patients to find that the kind of care needed to help sustain people through the worst cases of all forms of lung failure is highly similar. It just needs to be fine-tuned to focus on the damage COVID-19 does to the lungs. Read more.
Similar Factors Cause Health Disparities in Cancer, COVID-19
John Carethers, MD, MACP outlines the similar disparities occurring in cancer and COVID-19 and recommends potential policy changes and strategies to help improve outcomes. Read more.
First 10 Days After Leaving Hospital Carry High Risk for Veterans with COVID-19
Jack Iwashyna, MD, PhD and Hallie Prescott, MD, MSc compare outcomes of veterans with COVID-19 with those who had pneumonia or heat failure during the first 10 days after hospitalization. Read more.
Exploring a New Weapon Against COVID-19 Cytokine Storm
Lenar Yessayan, MD and H. David Humes, MD discuss their study that used extracorporeal selective cytopheretic device therapy that helped to wean two patients off ECMO. Read more.
RESEARCH AREAS, CENTERS, SYMPOSIUM & HISTORY
Learn more below about the research being conducted across our 13 divisions, our research centers, our annual research symposium, and our rich research history.
MICHIGAN MEDICINE - A RESEARCH POWERHOUSE
U-M researchers have access to robust services, equipment, testing, and technologies. Whether you are engaged in basic science research or clinical trials, U-M provides the support you need: